Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Yang, Huan ^a   Wang, Bo ^a   Wang, Tao ^a   Xu, Longjiang ^a   He, Chunyan ^a   Wen, Huiyan ^a   Yan, Jie ^a   Su, Honghong ^a   Zhu, Xueming ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; VASCULOTROPIN; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; BREAST METASTASIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GELATINASE A GENE; GELATINASE B GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TOLL LIKE RECEPTOR 4 GENE; VASCULOTROPIN GENE; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE; MCF 7 CELL LINE; PATHOLOGY; TUMOR INVASION;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHATIC METASTASIS; MCF-7 CELLS; MICE; MYELOID DIFFERENTIATION FACTOR 88; NEOPLASM INVASIVENESS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84907816018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109980     Document Type: Article

References (35)

1. Fidler IJ. (2003) The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-8.
2. Binns C, Low WY, Lee MK. (2013) Breast Cancer: An Increasing Public Health Problem in the Asia Pacific Region. Asia Pac J Public Health 25: 364-7.
3. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll proteins signals activation of adaptive immunity. Nature 388: 394-7.
4. Takeda K, Kaisho T, Akira S. (2003) Toll-like receptors. Annu. Rev. Immunol 21: 335-376.
5. Janeway CA Jr, Medzhitov R. (2002) Innate immune recognition. Annu Rev Immunol 20: 197-216.
6. Akira S, Uematsu S, Takeuchi O. (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
7. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. (2000) Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1: 398-401.
8. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. (2002) Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 99: 2281-6.
9. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, et al. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99-111.
10. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, et al. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370-7.
11. Szajnik M, Szczepanski MJ, Czystowska M, Elishaev E, Mandapathil M, et al. (2009) TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 28: 4353-63.
12. Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, et al. (2009) Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol 46: 2876-84.
13. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, et al. (2009) Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res 69: 3105-13.
14. Ahmed A, Redmond HP, Wang JH. (2013) Links between Toll-like receptor 4 and breast cancer. Oncoimmunology 2: e22945.
15. Liao SJ, Zhou YH, Yuan Y, Li D, Wu FH, et al. (2012) Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes avb3-mediated adhesion and invasive migration. Breast Cancer Res Treat 133: 853-63.
16. Ahmed A, Wang JH, Redmond HP. (2012) Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer. Ann Surg Oncol 1: 1-8.
17. Yang H, Zhou H, Feng P, Zhou X, Wen H, et al. (2010) Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 29: 92.
18. Lival KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-8.
19. ZuoY, Shields SK, Chakraborty C. (2006) Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem Biophys Res Commun 15: 361-367.
20. Pantel K, Brakenhoff RH. (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-56.
21. Wang G, Wang W, Zhou J, Yang X. (2013) Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer. Cancer Biomark 13: 21-8.
22. Di Domenico, M, Ricciardi C, Fusco A, Pierantoni GM. (2011) Anti-VEGF therapy in breast and lung mouse models of cancers. J Biomed Biotechnol 947928.
23. Kim SH, Cho NH, Kim K, Lee JS, Koo BS, et al. (2006) Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 93: 330-7.
24. Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, et al. (2011) Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg 253: 890-9.
25. Beachy PA, Karhadkar SS, Berman DM. (2004) Mending and malignancy. Nature 431: 402.
26. Schafer ZT, Brugge JS. (2007) IL-6 involvement in epithelial cancers. J Clin Invest 117: 3660-3.
27. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, et al. (2007) IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 117: 3988-4002.
28. Wang S, Yang J, Qian J, Wezeman M, Kwak LW, et al. (2006) Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood 107: 2432-9.
29. Wang L, Zhao Y, Qian J, Sun L, Lu Y, et al. (2012) Toll-Like Receptor-4 Signaling in Mantle Cell Lymphoma. Cancer 119: 782-91.
30. Zhang JJ, Wu HS, Wang L, Tian Y, Zhang JH, et al. (2010) Expression and significance of TLR4 and HIF- 1alpha in pancreatic ductal adenocarcinoma. World J Gastroenterol 16: 2881-8.
31. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, et al. (2010) High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 102: 908-15.
32. Gonzalez-Reyes S, Marin L, Gonzalez L, Gonzalez LO, del Casar JM, et al. (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10: 665.
33. Petricevic B, Vrbanec D, Jakic-Razumovic J, Brcic I, Rabic D, et al. (2012) Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer. Med Oncol 9: 486-94.
34. Ehsan N, Murad S, Ashiq T, Mansoor MU, Gul S, et al. (2013) Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast. Tumour Biol 34: 1053-9.
35. Wang XX, Wu Z, Huang HF, Han C, Zou W, et al. (2013) Caveolin-1, through its ability to negatively regulate TLR4, is a crucial determinant of MAPK activation in LPS-challenged mammary epithelial cells. Asian Pac J Cancer Prev 14: 2295-9.